Click for best price
Erectile Dysfunction Medication Market Size, Share 2023
| Market size in 2022 |
US$ 4995.6 million
|
Forecast Market size by 2029 |
US$ 6356.9 million
|
| Growth Rate |
CAGR of 3.5% |
Number of Pages |
65 Pages |
The global Erectile Dysfunction Medication market was valued at US$ 4995.6 million in 2022 and is projected to reach US$ 6356.9 million by 2029, at a CAGR of 3.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Erectile Dysfunction Medication market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Erectile Dysfunction Medication market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Erectile Dysfunction Medication market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Medication. This report contains market size and forecasts of Erectile Dysfunction Medication in global, including the following market information:
- Global Erectile Dysfunction Medication Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share.
The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.
We surveyed the Erectile Dysfunction Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erectile Dysfunction Medication Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Erectile Dysfunction Medication Market Segment Percentages, by Type, 2022 (%)
- Viagra
- Levitra
- Cialis
- Stendra
Global Erectile Dysfunction Medication Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Erectile Dysfunction Medication Market Segment Percentages, by Application, 2022 (%)
- Pharmacies
- Medical Institutions
- Pharmaceutical E-commerce
Global Erectile Dysfunction Medication Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Erectile Dysfunction Medication Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Erectile Dysfunction Medication revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Erectile Dysfunction Medication revenues share in global market, 2022 (%)
key players include:
- Pfizer
- Bayer
- Lilly
- Guangzhou Baiyunshan
- Qilu Pharmaceutical
- Yabang Pharmacy
- Hebei Changshan Biochemical
- Diao
- Guangzhou Hairui Pharmaceutical
- Chiatai Tianqing
- Jiangsu Tasly
- Chongqing Huapont
- Humanwell
Outline of Major Chapters:
Chapter 1: Introduces the definition of Erectile Dysfunction Medication, market overview.
Chapter 2: Global Erectile Dysfunction Medication market size in revenue.
Chapter 3: Detailed analysis of Erectile Dysfunction Medication company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Erectile Dysfunction Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Erectile Dysfunction Medication Market, Global Outlook and Forecast 2023-2032 |
| Market size in 2022 |
US$ 4995.6 million
|
| Forecast Market size by 2029 |
US$ 6356.9 million
|
| Growth Rate |
CAGR of 3.5% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Erectile Dysfunction Medication Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Erectile Dysfunction Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Erectile Dysfunction Medication Overall Market Size
2.1 Global Erectile Dysfunction Medication Market Size: 2022 VS 2032
2.2 Global Erectile Dysfunction Medication Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Erectile Dysfunction Medication Players in Global Market
3.2 Top Global Erectile Dysfunction Medication Companies Ranked by Revenue
3.3 Global Erectile Dysfunction Medication Revenue by Companies
3.4 Top 3 and Top 5 Erectile Dysfunction Medication Companies in Global Market, by Revenue in 2022
3.5 Global Companies Erectile Dysfunction Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Erectile Dysfunction Medication Players in Global Market
3.6.1 List of Global Tier 1 Erectile Dysfunction Medication Companies
3.6.2 List of Global Tier 2 and Tier 3 Erectile Dysfunction Medication Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Erectile Dysfunction Medication Market Size Markets, 2022 & 2032
4.1.2 Viagra
4.1.3 Levitra
4.1.4 Cialis
4.1.5 Stendra
4.2 By Type - Global Erectile Dysfunction Medication Revenue & Forecasts
4.2.1 By Type - Global Erectile Dysfunction Medication Revenue, 2018-2023
4.2.2 By Type - Global Erectile Dysfunction Medication Revenue, 2024-2032
4.2.3 By Type - Global Erectile Dysfunction Medication Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Erectile Dysfunction Medication Market Size, 2022 & 2032
5.1.2 Pharmacies
5.1.3 Medical Institutions
5.1.4 Pharmaceutical E-commerce
5.2 By Application - Global Erectile Dysfunction Medication Revenue & Forecasts
5.2.1 By Application - Global Erectile Dysfunction Medication Revenue, 2018-2023
5.2.2 By Application - Global Erectile Dysfunction Medication Revenue, 2024-2032
5.2.3 By Application - Global Erectile Dysfunction Medication Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Erectile Dysfunction Medication Market Size, 2022 & 2032
6.2 By Region - Global Erectile Dysfunction Medication Revenue & Forecasts
6.2.1 By Region - Global Erectile Dysfunction Medication Revenue, 2018-2023
6.2.2 By Region - Global Erectile Dysfunction Medication Revenue, 2024-2032
6.2.3 By Region - Global Erectile Dysfunction Medication Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Erectile Dysfunction Medication Revenue, 2018-2032
6.3.2 US Erectile Dysfunction Medication Market Size, 2018-2032
6.3.3 Canada Erectile Dysfunction Medication Market Size, 2018-2032
6.3.4 Mexico Erectile Dysfunction Medication Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Erectile Dysfunction Medication Revenue, 2018-2032
6.4.2 Germany Erectile Dysfunction Medication Market Size, 2018-2032
6.4.3 France Erectile Dysfunction Medication Market Size, 2018-2032
6.4.4 U.K. Erectile Dysfunction Medication Market Size, 2018-2032
6.4.5 Italy Erectile Dysfunction Medication Market Size, 2018-2032
6.4.6 Russia Erectile Dysfunction Medication Market Size, 2018-2032
6.4.7 Nordic Countries Erectile Dysfunction Medication Market Size, 2018-2032
6.4.8 Benelux Erectile Dysfunction Medication Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Erectile Dysfunction Medication Revenue, 2018-2032
6.5.2 China Erectile Dysfunction Medication Market Size, 2018-2032
6.5.3 Japan Erectile Dysfunction Medication Market Size, 2018-2032
6.5.4 South Korea Erectile Dysfunction Medication Market Size, 2018-2032
6.5.5 Southeast Asia Erectile Dysfunction Medication Market Size, 2018-2032
6.5.6 India Erectile Dysfunction Medication Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Erectile Dysfunction Medication Revenue, 2018-2032
6.6.2 Brazil Erectile Dysfunction Medication Market Size, 2018-2032
6.6.3 Argentina Erectile Dysfunction Medication Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Erectile Dysfunction Medication Revenue, 2018-2032
6.7.2 Turkey Erectile Dysfunction Medication Market Size, 2018-2032
6.7.3 Israel Erectile Dysfunction Medication Market Size, 2018-2032
6.7.4 Saudi Arabia Erectile Dysfunction Medication Market Size, 2018-2032
6.7.5 UAE Erectile Dysfunction Medication Market Size, 2018-2032
7 Erectile Dysfunction Medication Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Erectile Dysfunction Medication Major Product Offerings
7.1.4 Pfizer Erectile Dysfunction Medication Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Erectile Dysfunction Medication Major Product Offerings
7.2.4 Bayer Erectile Dysfunction Medication Revenue in Global Market (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 Lilly
7.3.1 Lilly Company Summary
7.3.2 Lilly Business Overview
7.3.3 Lilly Erectile Dysfunction Medication Major Product Offerings
7.3.4 Lilly Erectile Dysfunction Medication Revenue in Global Market (2018-2023)
7.3.5 Lilly Key News & Latest Developments
7.4 Guangzhou Baiyunshan
7.4.1 Guangzhou Baiyunshan Company Summary
7.4.2 Guangzhou Baiyunshan Business Overview
7.4.3 Guangzhou Baiyunshan Erectile Dysfunction Medication Major Product Offerings
7.4.4 Guangzhou Baiyunshan Erectile Dysfunction Medication Revenue in Global Market (2018-2023)
7.4.5 Guangzhou Baiyunshan Key News & Latest Developments
7.5 Qilu Pharmaceutical
7.5.1 Qilu Pharmaceutical Company Summary
7.5.2 Qilu Pharmaceutical Business Overview
7.5.3 Qilu Pharmaceutical Erectile Dysfunction Medication Major Product Offerings
7.5.4 Qilu Pharmaceutical Erectile Dysfunction Medication Revenue in Global Market (2018-2023)
7.5.5 Qilu Pharmaceutical Key News & Latest Developments
7.6 Yabang Pharmacy
7.6.1 Yabang Pharmacy Company Summary
7.6.2 Yabang Pharmacy Business Overview
7.6.3 Yabang Pharmacy Erectile Dysfunction Medication Major Product Offerings
7.6.4 Yabang Pharmacy Erectile Dysfunction Medication Revenue in Global Market (2018-2023)
7.6.5 Yabang Pharmacy Key News & Latest Developments
7.7 Hebei Changshan Biochemical
7.7.1 Hebei Changshan Biochemical Company Summary
7.7.2 Hebei Changshan Biochemical Business Overview
7.7.3 Hebei Changshan Biochemical Erectile Dysfunction Medication Major Product Offerings
7.7.4 Hebei Changshan Biochemical Erectile Dysfunction Medication Revenue in Global Market (2018-2023)
7.7.5 Hebei Changshan Biochemical Key News & Latest Developments
7.8 Diao
7.8.1 Diao Company Summary
7.8.2 Diao Business Overview
7.8.3 Diao Erectile Dysfunction Medication Major Product Offerings
7.8.4 Diao Erectile Dysfunction Medication Revenue in Global Market (2018-2023)
7.8.5 Diao Key News & Latest Developments
7.9 Guangzhou Hairui Pharmaceutical
7.9.1 Guangzhou Hairui Pharmaceutical Company Summary
7.9.2 Guangzhou Hairui Pharmaceutical Business Overview
7.9.3 Guangzhou Hairui Pharmaceutical Erectile Dysfunction Medication Major Product Offerings
7.9.4 Guangzhou Hairui Pharmaceutical Erectile Dysfunction Medication Revenue in Global Market (2018-2023)
7.9.5 Guangzhou Hairui Pharmaceutical Key News & Latest Developments
7.10 Chiatai Tianqing
7.10.1 Chiatai Tianqing Company Summary
7.10.2 Chiatai Tianqing Business Overview
7.10.3 Chiatai Tianqing Erectile Dysfunction Medication Major Product Offerings
7.10.4 Chiatai Tianqing Erectile Dysfunction Medication Revenue in Global Market (2018-2023)
7.10.5 Chiatai Tianqing Key News & Latest Developments
7.11 Jiangsu Tasly
7.11.1 Jiangsu Tasly Company Summary
7.11.2 Jiangsu Tasly Business Overview
7.11.3 Jiangsu Tasly Erectile Dysfunction Medication Major Product Offerings
7.11.4 Jiangsu Tasly Erectile Dysfunction Medication Revenue in Global Market (2018-2023)
7.11.5 Jiangsu Tasly Key News & Latest Developments
7.12 Chongqing Huapont
7.12.1 Chongqing Huapont Company Summary
7.12.2 Chongqing Huapont Business Overview
7.12.3 Chongqing Huapont Erectile Dysfunction Medication Major Product Offerings
7.12.4 Chongqing Huapont Erectile Dysfunction Medication Revenue in Global Market (2018-2023)
7.12.5 Chongqing Huapont Key News & Latest Developments
7.13 Humanwell
7.13.1 Humanwell Company Summary
7.13.2 Humanwell Business Overview
7.13.3 Humanwell Erectile Dysfunction Medication Major Product Offerings
7.13.4 Humanwell Erectile Dysfunction Medication Revenue in Global Market (2018-2023)
7.13.5 Humanwell Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Erectile Dysfunction Medication Market Opportunities & Trends in Global Market
Table 2. Erectile Dysfunction Medication Market Drivers in Global Market
Table 3. Erectile Dysfunction Medication Market Restraints in Global Market
Table 4. Key Players of Erectile Dysfunction Medication in Global Market
Table 5. Top Erectile Dysfunction Medication Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Erectile Dysfunction Medication Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Erectile Dysfunction Medication Revenue Share by Companies, 2018-2023
Table 8. Global Companies Erectile Dysfunction Medication Product Type
Table 9. List of Global Tier 1 Erectile Dysfunction Medication Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Erectile Dysfunction Medication Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Erectile Dysfunction Medication Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Erectile Dysfunction Medication Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Erectile Dysfunction Medication Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Erectile Dysfunction Medication Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Erectile Dysfunction Medication Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Erectile Dysfunction Medication Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Erectile Dysfunction Medication Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Erectile Dysfunction Medication Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Erectile Dysfunction Medication Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Erectile Dysfunction Medication Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Erectile Dysfunction Medication Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Erectile Dysfunction Medication Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Erectile Dysfunction Medication Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Erectile Dysfunction Medication Revenue, (US$, Mn), 2024-2032
Table 30. Pfizer Company Summary
Table 31. Pfizer Erectile Dysfunction Medication Product Offerings
Table 32. Pfizer Erectile Dysfunction Medication Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Bayer Company Summary
Table 35. Bayer Erectile Dysfunction Medication Product Offerings
Table 36. Bayer Erectile Dysfunction Medication Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer Key News & Latest Developments
Table 38. Lilly Company Summary
Table 39. Lilly Erectile Dysfunction Medication Product Offerings
Table 40. Lilly Erectile Dysfunction Medication Revenue (US$, Mn) & (2018-2023)
Table 41. Lilly Key News & Latest Developments
Table 42. Guangzhou Baiyunshan Company Summary
Table 43. Guangzhou Baiyunshan Erectile Dysfunction Medication Product Offerings
Table 44. Guangzhou Baiyunshan Erectile Dysfunction Medication Revenue (US$, Mn) & (2018-2023)
Table 45. Guangzhou Baiyunshan Key News & Latest Developments
Table 46. Qilu Pharmaceutical Company Summary
Table 47. Qilu Pharmaceutical Erectile Dysfunction Medication Product Offerings
Table 48. Qilu Pharmaceutical Erectile Dysfunction Medication Revenue (US$, Mn) & (2018-2023)
Table 49. Qilu Pharmaceutical Key News & Latest Developments
Table 50. Yabang Pharmacy Company Summary
Table 51. Yabang Pharmacy Erectile Dysfunction Medication Product Offerings
Table 52. Yabang Pharmacy Erectile Dysfunction Medication Revenue (US$, Mn) & (2018-2023)
Table 53. Yabang Pharmacy Key News & Latest Developments
Table 54. Hebei Changshan Biochemical Company Summary
Table 55. Hebei Changshan Biochemical Erectile Dysfunction Medication Product Offerings
Table 56. Hebei Changshan Biochemical Erectile Dysfunction Medication Revenue (US$, Mn) & (2018-2023)
Table 57. Hebei Changshan Biochemical Key News & Latest Developments
Table 58. Diao Company Summary
Table 59. Diao Erectile Dysfunction Medication Product Offerings
Table 60. Diao Erectile Dysfunction Medication Revenue (US$, Mn) & (2018-2023)
Table 61. Diao Key News & Latest Developments
Table 62. Guangzhou Hairui Pharmaceutical Company Summary
Table 63. Guangzhou Hairui Pharmaceutical Erectile Dysfunction Medication Product Offerings
Table 64. Guangzhou Hairui Pharmaceutical Erectile Dysfunction Medication Revenue (US$, Mn) & (2018-2023)
Table 65. Guangzhou Hairui Pharmaceutical Key News & Latest Developments
Table 66. Chiatai Tianqing Company Summary
Table 67. Chiatai Tianqing Erectile Dysfunction Medication Product Offerings
Table 68. Chiatai Tianqing Erectile Dysfunction Medication Revenue (US$, Mn) & (2018-2023)
Table 69. Chiatai Tianqing Key News & Latest Developments
Table 70. Jiangsu Tasly Company Summary
Table 71. Jiangsu Tasly Erectile Dysfunction Medication Product Offerings
Table 72. Jiangsu Tasly Erectile Dysfunction Medication Revenue (US$, Mn) & (2018-2023)
Table 73. Jiangsu Tasly Key News & Latest Developments
Table 74. Chongqing Huapont Company Summary
Table 75. Chongqing Huapont Erectile Dysfunction Medication Product Offerings
Table 76. Chongqing Huapont Erectile Dysfunction Medication Revenue (US$, Mn) & (2018-2023)
Table 77. Chongqing Huapont Key News & Latest Developments
Table 78. Humanwell Company Summary
Table 79. Humanwell Erectile Dysfunction Medication Product Offerings
Table 80. Humanwell Erectile Dysfunction Medication Revenue (US$, Mn) & (2018-2023)
Table 81. Humanwell Key News & Latest Developments
List of Figures
Figure 1. Erectile Dysfunction Medication Segment by Type in 2022
Figure 2. Erectile Dysfunction Medication Segment by Application in 2022
Figure 3. Global Erectile Dysfunction Medication Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Erectile Dysfunction Medication Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Erectile Dysfunction Medication Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Erectile Dysfunction Medication Revenue in 2022
Figure 8. By Type - Global Erectile Dysfunction Medication Revenue Market Share, 2018-2032
Figure 9. By Application - Global Erectile Dysfunction Medication Revenue Market Share, 2018-2032
Figure 10. By Type - Global Erectile Dysfunction Medication Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Erectile Dysfunction Medication Revenue Market Share, 2018-2032
Figure 12. By Application - Global Erectile Dysfunction Medication Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Erectile Dysfunction Medication Revenue Market Share, 2018-2032
Figure 14. By Region - Global Erectile Dysfunction Medication Revenue Market Share, 2018-2032
Figure 15. By Country - North America Erectile Dysfunction Medication Revenue Market Share, 2018-2032
Figure 16. US Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Erectile Dysfunction Medication Revenue Market Share, 2018-2032
Figure 20. Germany Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 21. France Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Erectile Dysfunction Medication Revenue Market Share, 2018-2032
Figure 28. China Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 32. India Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Erectile Dysfunction Medication Revenue Market Share, 2018-2032
Figure 34. Brazil Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Erectile Dysfunction Medication Revenue Market Share, 2018-2032
Figure 37. Turkey Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Erectile Dysfunction Medication Revenue, (US$, Mn), 2018-2032
Figure 41. Pfizer Erectile Dysfunction Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer Erectile Dysfunction Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Lilly Erectile Dysfunction Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Guangzhou Baiyunshan Erectile Dysfunction Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Qilu Pharmaceutical Erectile Dysfunction Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Yabang Pharmacy Erectile Dysfunction Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Hebei Changshan Biochemical Erectile Dysfunction Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Diao Erectile Dysfunction Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Guangzhou Hairui Pharmaceutical Erectile Dysfunction Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Chiatai Tianqing Erectile Dysfunction Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Jiangsu Tasly Erectile Dysfunction Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Chongqing Huapont Erectile Dysfunction Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Humanwell Erectile Dysfunction Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
